Valentin H Meissner1, Kathleen Herkommer1, Birgitt Marten-Mittag2, Jürgen E Gschwend1, Andreas Dinkel3. 1. Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany. 2. Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, Technical University of Munich, Langerstr. 3, 81675, Munich, Germany. 3. Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, Technical University of Munich, Langerstr. 3, 81675, Munich, Germany. a.dinkel@tum.de.
Abstract
PURPOSE: Knowledge of the psychological distress of long- and very long-term (>10 years) prostate cancer (PC) survivors is limited. This study intended to examine the parameters influencing anxiety related to prostate-specific antigen (PSA) and PC in long-term survivors after radical prostatectomy. METHODS: We surveyed 4719 PC survivors from the German multicenter prospective database "Familial Prostate Cancer." We evaluated the association of PC-related anxiety (MAX-PC) with sociodemographic characteristics, family history of PC, global health status/quality of life (EORTC QLQ-C30), depression and anxiety (PHQ-2; GAD-2), latest PSA level, time since radical prostatectomy, and current therapy. RESULTS: The survey participants' mean age was 75.2 years (SD = 6.5). Median follow-up was 11.5 years, and 19.5% of participants had survived more than 15 years since the initial treatment. The final regression analysis found that younger age, lower global health status/quality of life, higher depression and anxiety scores, higher latest PSA level, and shorter time since radical prostatectomy predicted increased PSA-related anxiety and PC anxiety. Familial PC was predictive only of PSA anxiety (all p < 0.05). The final model explained 12% of the variance for PSA anxiety and 24% for PC anxiety. CONCLUSIONS: PC-related anxiety remained relevant many years after prostatectomy and was influenced by younger age, psychological status, rising PSA level, and shorter time since initial treatment. IMPLICATIONS FOR CANCER SURVIVORS: Survivors with these characteristics are at increased risk of PC-related anxieties, which should be considered by the treating physician during follow-up.
PURPOSE: Knowledge of the psychological distress of long- and very long-term (>10 years) prostate cancer (PC) survivors is limited. This study intended to examine the parameters influencing anxiety related to prostate-specific antigen (PSA) and PC in long-term survivors after radical prostatectomy. METHODS: We surveyed 4719 PC survivors from the German multicenter prospective database "Familial Prostate Cancer." We evaluated the association of PC-related anxiety (MAX-PC) with sociodemographic characteristics, family history of PC, global health status/quality of life (EORTC QLQ-C30), depression and anxiety (PHQ-2; GAD-2), latest PSA level, time since radical prostatectomy, and current therapy. RESULTS: The survey participants' mean age was 75.2 years (SD = 6.5). Median follow-up was 11.5 years, and 19.5% of participants had survived more than 15 years since the initial treatment. The final regression analysis found that younger age, lower global health status/quality of life, higher depression and anxiety scores, higher latest PSA level, and shorter time since radical prostatectomy predicted increased PSA-related anxiety and PC anxiety. Familial PC was predictive only of PSAanxiety (all p < 0.05). The final model explained 12% of the variance for PSAanxiety and 24% for PC anxiety. CONCLUSIONS: PC-related anxiety remained relevant many years after prostatectomy and was influenced by younger age, psychological status, rising PSA level, and shorter time since initial treatment. IMPLICATIONS FOR CANCER SURVIVORS: Survivors with these characteristics are at increased risk of PC-related anxieties, which should be considered by the treating physician during follow-up.
Authors: Benjamin A Spencer; Susan H Babey; David A Etzioni; Ninez A Ponce; E Richard Brown; Hongjian Yu; Neetu Chawla; Mark S Litwin Journal: Cancer Date: 2006-02-15 Impact factor: 6.860
Authors: Hung-Jui Tan; Leonard S Marks; Michael A Hoyt; Lorna Kwan; Christopher P Filson; Malu Macairan; Patricia Lieu; Mark S Litwin; Annette L Stanton Journal: J Urol Date: 2016-02-09 Impact factor: 7.450
Authors: Megan Johnson Shen; Christian J Nelson; Ellen Peters; Susan F Slovin; Simon J Hall; Matt Hall; Phapichaya Chaoprang Herrera; Elaine A Leventhal; Howard Leventhal; Michael A Diefenbach Journal: Med Decis Making Date: 2014-11-10 Impact factor: 2.583
Authors: Lionne D F Venderbos; Roderick C N van den Bergh; Monique J Roobol; Fritz H Schröder; Marie-Louise Essink-Bot; Chris H Bangma; Ewout W Steyerberg; Ida J Korfage Journal: Psychooncology Date: 2014-08-20 Impact factor: 3.894
Authors: Bettina Meiser; Ruth Cowan; Anthony Costello; Graham G Giles; Geoff J Lindeman; Clara L Gaff Journal: Urology Date: 2007-10 Impact factor: 2.649
Authors: Andrea M Tavlarides; Steven C Ames; Nancy N Diehl; Richard W Joseph; Erik P Castle; David D Thiel; Gregory A Broderick; Alexander S Parker Journal: Psychooncology Date: 2012-08-01 Impact factor: 3.894
Authors: Anna T Gavin; Frances J Drummond; Conan Donnelly; Eamonn O'Leary; Linda Sharp; Heather R Kinnear Journal: BJU Int Date: 2015-06-22 Impact factor: 5.588
Authors: Amy Y Zhang; Stephen Ganocy; Alex Z Fu; Denise Kresevic; Lee Ponsky; Gerald Strauss; Donald R Bodner; Hui Zhu Journal: Support Care Cancer Date: 2019-03-22 Impact factor: 3.603
Authors: Konstantina G Yiannopoulou; Aikaterini I Anastasiou; Konstantinos Kontoangelos; Charalambos Papageorgiou; Ioannis P Anastasiou Journal: Curr Urol Date: 2020-12-18
Authors: Irène Lassmann; Andreas Dinkel; Birgitt Marten-Mittag; Matthias Jahnen; Helga Schulwitz; Jürgen E Gschwend; Kathleen Herkommer Journal: Support Care Cancer Date: 2021-01-15 Impact factor: 3.359
Authors: Daniel O Erim; Antonia V Bennett; Bradley N Gaynes; Ram S Basak; Deborah Usinger; Ronald C Chen Journal: Cancer Med Date: 2020-04-23 Impact factor: 4.452
Authors: Jamie M Faro; Kristin M Mattocks; Catherine S Nagawa; Stephenie C Lemon; Bo Wang; Sarah L Cutrona; Rajani S Sadasivam Journal: JMIR Cancer Date: 2021-02-03
Authors: Ernesto Sánchez Sánchez; Antonio Carlos González Baena; Carlos González Cáliz; Fernando Caballero Paredes; José Luis Moyano Calvo; Jesús Castiñeiras Fernández Journal: Prostate Cancer Date: 2020-01-29